抗凝治疗对特发性肺动脉高压病人十分重要，但是在治疗ES方面存在争论，因为出血风险高。

Anticoagulants, which are an important part of therapy for many patients with idiopathic pulmonary hypertension, are controversial in ES, because of the high risk for bleeding complications.

youdao

ES病人与那些未经治疗的特发性肺动脉高压病人比较，生存率更佳。

Patients with ES show significantly more favorable survival rates, as compared with those with untreated idiopathic pulmonary hypertension.

youdao

ES病人与那些未经治疗的特发性肺动脉高压病人比较，生存率更佳。

Patients with ES show significantly more favorable survival rates, as compared with those with untreated idiopathic pulmonary hypertension.

youdao